EP3439637
PROCESS FOR MESALAZINE SOLID FORMULATIONS
Mit der Maus auf einen Inhaber zeigen, um die Daten zu sehen
- Alfasigma s.p.a.seit 28. Apr. 2023
- SOFAR S.p.A.11. Jan. 2019 – 28. Apr. 2023
The present invention relates to a process to prepare solid pharmaceutical forms comprising a quantity of mesalazine comprised between 75 and 95%, i.e. between 1000 and 1600 mg of drug per dosage unit. Furthermore, the present invention relates to a granulate and/or tablets obtained/obtainable with the process according to the invention, preferably coated to allow the controlled release of the drug. Finally, the present invention relates to the use of the granulate and/or the tablets as a medicament, preferably for the treatment of chronic inflammatory pathologies that preferably affect the intestinal tract.
Aus der internationalen Anmeldung WO2017175123
| Datum | Verfahren | Kammer | Art | Ergebnis | Parteien |
|---|---|---|---|---|---|
| 29. Mai 2026 | UPC CFI 1920/2026 | Milan LD | Einstweilige Verfügung | Gesperrt | Alfasigma s.p.a. +2 |
Weitere Verfahren zu diesem Patent